I'd love to help Gelxi, but with my modest holding of just 60k, it's probably not worth it, but you can add my name to the list if you need volume john.aitken-at-westnet.com.au
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025